Cargando…

Gut microbiome-mediated mechanisms in aging-related diseases: are probiotics ready for prime time?

Chronic low-grade inflammation affects health and is associated with aging and age-related diseases. Dysregulation of the gut flora is an important trigger for chronic low-grade inflammation. Changes in the composition of the gut flora and exposure to related metabolites have an effect on the inflam...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Jing, Li, Huimin, Zeng, Guixing, Pang, Boxian, Wang, Qiuhong, Wei, Junping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267478/
https://www.ncbi.nlm.nih.gov/pubmed/37324466
http://dx.doi.org/10.3389/fphar.2023.1178596
_version_ 1785058937376079872
author Ren, Jing
Li, Huimin
Zeng, Guixing
Pang, Boxian
Wang, Qiuhong
Wei, Junping
author_facet Ren, Jing
Li, Huimin
Zeng, Guixing
Pang, Boxian
Wang, Qiuhong
Wei, Junping
author_sort Ren, Jing
collection PubMed
description Chronic low-grade inflammation affects health and is associated with aging and age-related diseases. Dysregulation of the gut flora is an important trigger for chronic low-grade inflammation. Changes in the composition of the gut flora and exposure to related metabolites have an effect on the inflammatory system of the host. This results in the development of crosstalk between the gut barrier and immune system, contributing to chronic low-grade inflammation and impairment of health. Probiotics can increase the diversity of gut microbiota, protect the gut barrier, and regulate gut immunity, thereby reducing inflammation. Therefore, the use of probiotics is a promising strategy for the beneficial immunomodulation and protection of the gut barrier through gut microbiota. These processes might positively influence inflammatory diseases, which are common in the elderly.
format Online
Article
Text
id pubmed-10267478
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102674782023-06-15 Gut microbiome-mediated mechanisms in aging-related diseases: are probiotics ready for prime time? Ren, Jing Li, Huimin Zeng, Guixing Pang, Boxian Wang, Qiuhong Wei, Junping Front Pharmacol Pharmacology Chronic low-grade inflammation affects health and is associated with aging and age-related diseases. Dysregulation of the gut flora is an important trigger for chronic low-grade inflammation. Changes in the composition of the gut flora and exposure to related metabolites have an effect on the inflammatory system of the host. This results in the development of crosstalk between the gut barrier and immune system, contributing to chronic low-grade inflammation and impairment of health. Probiotics can increase the diversity of gut microbiota, protect the gut barrier, and regulate gut immunity, thereby reducing inflammation. Therefore, the use of probiotics is a promising strategy for the beneficial immunomodulation and protection of the gut barrier through gut microbiota. These processes might positively influence inflammatory diseases, which are common in the elderly. Frontiers Media S.A. 2023-06-01 /pmc/articles/PMC10267478/ /pubmed/37324466 http://dx.doi.org/10.3389/fphar.2023.1178596 Text en Copyright © 2023 Ren, Li, Zeng, Pang, Wang and Wei. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Ren, Jing
Li, Huimin
Zeng, Guixing
Pang, Boxian
Wang, Qiuhong
Wei, Junping
Gut microbiome-mediated mechanisms in aging-related diseases: are probiotics ready for prime time?
title Gut microbiome-mediated mechanisms in aging-related diseases: are probiotics ready for prime time?
title_full Gut microbiome-mediated mechanisms in aging-related diseases: are probiotics ready for prime time?
title_fullStr Gut microbiome-mediated mechanisms in aging-related diseases: are probiotics ready for prime time?
title_full_unstemmed Gut microbiome-mediated mechanisms in aging-related diseases: are probiotics ready for prime time?
title_short Gut microbiome-mediated mechanisms in aging-related diseases: are probiotics ready for prime time?
title_sort gut microbiome-mediated mechanisms in aging-related diseases: are probiotics ready for prime time?
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267478/
https://www.ncbi.nlm.nih.gov/pubmed/37324466
http://dx.doi.org/10.3389/fphar.2023.1178596
work_keys_str_mv AT renjing gutmicrobiomemediatedmechanismsinagingrelateddiseasesareprobioticsreadyforprimetime
AT lihuimin gutmicrobiomemediatedmechanismsinagingrelateddiseasesareprobioticsreadyforprimetime
AT zengguixing gutmicrobiomemediatedmechanismsinagingrelateddiseasesareprobioticsreadyforprimetime
AT pangboxian gutmicrobiomemediatedmechanismsinagingrelateddiseasesareprobioticsreadyforprimetime
AT wangqiuhong gutmicrobiomemediatedmechanismsinagingrelateddiseasesareprobioticsreadyforprimetime
AT weijunping gutmicrobiomemediatedmechanismsinagingrelateddiseasesareprobioticsreadyforprimetime